Navigation Links
Vermillion Reports Fourth Quarter and Full Year 2012 Results
Date:2/20/2013

uest Diagnostics which were resolved in 2012 (at $60 per resolved test). The resolved tests include both reimbursed and unreimbursed tests for which Quest Diagnostics considers the payment status as final.

By comparison, revenue in the fourth quarter of 2011 included $206,000 of product revenue from 4,118 OVA1 tests performed (at the fixed $50 per test), and $549,000 for the variable 33% royalty from 11,708 OVA1 tests reported by Quest Diagnostics as resolved in 2011 (at $47 per resolved test).

Total revenue for the full year 2012 increased 9% to $2.1 million from $1.9 million in 2011. Total revenue in 2012 was comprised of $1.6 million in product sales of OVA1 and $454,000 in license revenue. Product sales of OVA1 in 2012 include $824,000 from 16,460 OVA1 tests performed (at the fixed $50 per test) and $816,000 from the 33% royalty reported by Quest Diagnostics for 2012.

By comparison, revenue in 2011 included $1.5 million from product sales of OVA1 and $454,000 of license revenue. Product sales of OVA1 in 2011 were comprised of $761,000 from 15,225 OVA1 tests performed (at the fixed $50 per test), $549,000 from the 33% royalty reported by Quest Diagnostics for 2011, and $159,000 from the 33% royalties reported by Quest Diagnostics for 2010. The 2010 royalty was reported by Quest Diagnostics and recorded by the company in the first quarter of 2011.

Total operating expenses in the fourth quarter of 2012 decreased to $2.4 million from $3.9 million in the same year-ago quarter. Operating expenses for the full year 2012 decreased to $11.4 million from $19.4 million in 2011, primarily due to lower clinical trial costs for the ongoing development of the company's ovarian cancer franchise and PAD program, as well as lower overall headcount and stock-based compensation charges compared to the prior year. Research and development expenses for the prior year also included $435,000 for the Correlogic asset acquisition.

Fourth quarter 2012
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
2. Vermillion Announces CEO Succession Plan
3. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion Reports Second Quarter 2012 Results
6. Vermillion to Present at the 2012 Gateway Conference on September 6
7. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
8. Vermillion Reports Third Quarter 2012 Results
9. Delaware Court of Chancery Dismisses Vermillion Dissident Shareholder Suit with Prejudice
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)...  Sage Analytics ( www.sageanalytics.com ), the developers of ... systems, announced its sponsorship of the California Cannabis Industry ... number of tickets are available for groups or individuals ... while enjoying an open bar, buffet dinner and hors ... Bay at sunset. With the legislative session ...
(Date:8/3/2015)...  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" or ... HZNP ) ("Horizon") announcement that it intends to ... a record date to determine the shareholders eligible to ... Board will review the request when it is received. ... the information required under Depomed,s bylaws, the Depomed Board ...
(Date:8/3/2015)... , August 3, 2015 ... by Persistence Market Research "Global Market Study on ... to Witness Highest Growth by 2022", the global physiotherapy ... Bn by the end of 2015 and is expected ... 2015 to 2022, to account for US$23.7 Bn by ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4
... Aug. 24 GE Healthcare is proud to ... is now included in the company,s ecomagination(SM) campaign. ... contrast media, offers significant advantages over traditional glass ... healthcare workers who administer contrast media to patients, ...
... Aug. 24 Regenicin, Inc. ... biotechnology company, announced today that Dr. Joseph Rubinfeld, one of ... agreed to join the company,s board of directors. Dr. Rubinfeld ... PermaDerm™, Regenicin,s proprietary autologous cultured skin ...
Cached Medicine Technology:+PLUSPAK (polymer bottle) Packaging Receives GE's Distinguished ecomagination(SM) Approval 2+PLUSPAK (polymer bottle) Packaging Receives GE's Distinguished ecomagination(SM) Approval 3Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors 2
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health Food ... its website. , “Our ‘Ask a Nutritionist’ feature on our website is a free ... said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health Food Grocers’ ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Journal Constitution, the new Lifetime reality series, “Atlanta Plastic” is getting attention for ... receives plastic surgery, with its predominantly African-American cast of doctors and patients. Beverly ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of Appeals ruled in favor of the firm’s client Rebecca Hamsher, deciding that ... Medical Center must reimburse benefits for Hamsher’s residential treatment for bulimia, depression and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the ... to offer pharmacogenetic lab testing and precision medicine solutions that can help pharmacists ... , Annually, more than 8.6 million adverse drug events are reported in the ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3
... ... with HCG Diet Drops , ... 14, 2010 -- It is no secret that obesity has reached epidemic proportions in our country. ... as a result of the extra pounds. , , ,But thanks to the HCG ...
... ... accident claims service National Accident Helpline warns of the dangers of cycling injuries and urges caution ... (PRWEB) June 14, ... to prevent cycling injuries now the improving weather is seeing an increasing number of people take ...
... ... the amazing true tale of one man,s journey of growing up in poverty ... a college degree. He decided to make a difference in the lives ... numerous local and national awards for his community work. He took his ...
... ... software is pleased to welcome Click2Scan Ltd. a document scanning specialist, and document management software ... ... Ltd. www.click2scan.co.uk with offices in Wiltshire and London is one of the fastest ...
... ... Jazz Festival, , ... Newport, R.I. (PRWEB) June 14, 2010 -- New Festival Productions today announced that discounted ... the 2010 CareFusion Newport Jazz Festival in Newport, RI, August 6-8. Generously donated by ...
... ... in cosmetic, facial plastic, and reconstructive surgery, understands that women need options. With an ... an alternative method to breast implant surgery. Natural breast augmentation allows patients the opportunity ... ...
Cached Medicine News:Health News:Thousands Drop The Weight For Good with HCG Diet Drops 2Health News:Break The Injury Cycle, Says National Accident Helpline 2Health News:Celebrated Father Overcame Poverty and Mental Illness to Help His Son Earn a Scholarship to Harvard 2Health News:FileHold Document Management Software welcomes Click2ScanLtd. as a Value Added Re-sellers in the UK 2Health News:CareFusion Newport Jazz Festival Discounts Tickets for Health Care Practitioners 2Health News:Del Mar Plastic Surgeon Dr. Maurice Sherman Now Offering Natural Breast Implant Alternatives 2
Prognosis / Patient Management. HIV-1 Viral Load Assay. NucliSens HIV-1 QT covers the entire dynamic range of viral load testing from a single patient sample, without reflex testing or thermalcycli...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca...
... OraQuick ADVANCE Rapid HIV-1/2 ... single-use, qualitative immunoassay to ... Immunodeficiency Virus Type 1 ... (HIV-2) in oral fluid, ...
... performance benefits of TiMAX material have been applied ... Greater strength and an ultra-low profile combine to ... the lower extremity. , ,This complete set of ... Plate , Fibula Composite Plate ...
Medicine Products: